Literature DB >> 11983774

Fusidic acid monotherapy.

V Vassiliou, A K Demetriades, G Scott.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11983774      PMCID： PMC1279694     

Source DB:  PubMed          Journal:  J R Soc Med        ISSN： 0141-0768            Impact factor:   5.344


× No keyword cloud information.
  6 in total

Review 1.  Resistance to fusidic acid.

Authors:  J Turnidge; P Collignon
Journal:  Int J Antimicrob Agents       Date:  1999-08       Impact factor: 5.283

2.  Oral fusidic acid fails to eradicate methicillin-resistant Staphylococcus aureus colonization and results in emergence of fusidic acid-resistant strains.

Authors:  S C Chang; S M Hsieh; M L Chen; W H Sheng; Y C Chen
Journal:  Diagn Microbiol Infect Dis       Date:  2000-02       Impact factor: 2.803

3.  Increases in the mutation frequency at which fusidic acid-resistant Staphylococcus aureus arise with salicylate.

Authors:  Christopher T D Price; John E Gustafson
Journal:  J Med Microbiol       Date:  2001-01       Impact factor: 2.472

4.  Growth in the presence of salicylate increases fluoroquinolone resistance in Staphylococcus aureus.

Authors:  J E Gustafson; P V Candelaria; S A Fisher; J P Goodridge; T M Lichocik; T M McWilliams; C T Price; F G O'Brien; W B Grubb
Journal:  Antimicrob Agents Chemother       Date:  1999-04       Impact factor: 5.191

Review 5.  Optimum treatment of staphylococcal infections.

Authors:  J Turnidge; M L Grayson
Journal:  Drugs       Date:  1993-03       Impact factor: 9.546

6.  Hypocalcaemia during fusidic acid therapy.

Authors:  M Biswas; K Owen; M K Jones
Journal:  J R Soc Med       Date:  2002-02       Impact factor: 18.000
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.